Valeant mulls three new directors including one from Pershing Square: source

Embattled drug company Valeant Pharmaceuticals , whose stock price has tumbled 38 percent this year, is mulling giving board seats to activist hedge fund Pershing Square Capital Management, one of its biggest investors, and two other people, a person familiar with the matter said. Stephen Fraidin, a veteran Wall Street lawyer who is now vice chairman at William Ackman's Pershing Square, is expected to join Valeant's 12-member board, two people familiar with the matter said. The company is also e